A detailed history of Coppell Advisory Solutions LLC transactions in Mannkind Corp stock. As of the latest transaction made, Coppell Advisory Solutions LLC holds 608 shares of MNKD stock, worth $3,277. This represents 0.0% of its overall portfolio holdings.

Number of Shares
608
Previous 616 1.3%
Holding current value
$3,277
Previous $3.25 Million 31.82%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$3.34 - $4.29 $26 - $34
-8 Reduced 1.3%
608 $2.21 Million
Q2 2023

Aug 17, 2023

BUY
$3.72 - $4.79 $2,291 - $2,950
616 New
616 $2.44 Million
Q1 2023

May 19, 2023

SELL
$3.95 - $5.63 $2,433 - $3,468
-616 Closed
0 $0
Q4 2022

May 19, 2023

BUY
$3.02 - $5.37 $1,860 - $3,307
616 New
616 $3.25 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.39B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Coppell Advisory Solutions LLC Portfolio

Follow Coppell Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions LLC with notifications on news.